Globus Medical Inc. Class A Common Stock vs PPG Industries, Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while PPG Industries, Inc. trades at $104.87 (market cap $23.31B). The key difference: PPG Industries, Inc. is far larger — about 2.3× Globus Medical Inc. Class A Common Stock's market cap, and PPG Industries, Inc. pays a 2.82% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and PPG Industries, Inc. for 68 Days on average.
| GMED | PPG | |
|---|---|---|
Market Cap | $10.25B | $23.31B |
Volume | 1,059,528 | 1,812,724 |
Sector | Health | Basic Materials |
52-Week High | $96.82 | $131.56 |
52-Week Low | $58.33 | $94.34 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $9.76B | $29.18B |
Dividend Yield | — | 2.82% |
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
PPG Industries trades at $104.55, up 0.81% on the day, with a bearish technical signal from moving averages and oscillators. The company reported mixed Q2 2026 earnings, missing EPS estimates but showing 7% revenue growth. Fundamentals are solid with a P/E of 15, net income margin of 9.57%, and strong cash flow from operations of $1.94B in 2025. Recent news highlights innovation initiatives and leadership appointments aimed at driving growth.
The outlook is cautiously optimistic with a consensus price target of $130.50, implying 25% upside, supported by 55% analyst buy ratings. Key risks include margin pressures in the Automotive Refinish segment and macroeconomic headwinds in Europe. The stock offers value at current levels but requires monitoring of Q3 earnings on Oct 27 for confirmation of growth trajectory.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →